Please use this identifier to cite or link to this item: https://doi.org/10.1097/OPX.0b013e31826f32e0
DC FieldValue
dc.titleLipid-containing lubricants for dry eye: A systematic review
dc.contributor.authorLee, S.-Y.
dc.contributor.authorTong, L.
dc.date.accessioned2014-11-26T08:32:13Z
dc.date.available2014-11-26T08:32:13Z
dc.date.issued2012-11
dc.identifier.citationLee, S.-Y., Tong, L. (2012-11). Lipid-containing lubricants for dry eye: A systematic review. Optometry and Vision Science 89 (11) : 1654-1661. ScholarBank@NUS Repository. https://doi.org/10.1097/OPX.0b013e31826f32e0
dc.identifier.issn10405488
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/110433
dc.description.abstractPURPOSE: Dry eye is a common eye condition with significant impact on its sufferers' quality of life. We conducted a systematic review of randomized controlled treatment trials to assess the effectiveness of lipid-containing lubricants (LCLs) on dry eye treatment. METHODS: An online database was searched without any language or date restrictions. Clinical trials on LCL with non-lipid-containing control eyedrops were included. The outcome measures of each study (including symptoms and clinical signs), their risk of bias (assessed using the Cochrane tool), and strength of evidence were discussed. RESULTS: Three studies on liposomal lid sprays and four on lipid-containing eyedrops were included. All studies found significant improvements in most of the symptoms/signs of dry eye in patients who used LCL during the study period. Subjects in all trials reported greater symptom relief with LCLs, although this was shown to be short lived in two studies. Lipid layer structure improvement after LCLs application was demonstrated in two studies, although only up to 90 min in one study. Improvement in Schirmer test results was shown in two out of four studies, tear breakup time in four out of five studies, meibomian gland status in three out of three studies, conjunctival folds and tear evaporation rates in two out of two studies each. None of the studies were completely free of risks of bias; only three studies were double masked. Three of the studies were assigned high level of evidence, three were assigned as moderate evidence, and the final one low level of evidence. CONCLUSIONS: Most studies have demonstrated the effectiveness of LCLs on improving select signs of dry eye. Based on the overall substantial level of evidence, this type of eyedrop can be recommended for use in clinical practice where the aim is to reduce the signs and symptoms of dry eye. Copyright © 2012 American Academy of Optometry.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1097/OPX.0b013e31826f32e0
dc.sourceScopus
dc.subjectdry eye
dc.subjecteyedrops
dc.subjecthuman
dc.subjectlipid layer
dc.subjectliposomal spray
dc.typeReview
dc.contributor.departmentDUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
dc.description.doi10.1097/OPX.0b013e31826f32e0
dc.description.sourcetitleOptometry and Vision Science
dc.description.volume89
dc.description.issue11
dc.description.page1654-1661
dc.description.codenOVSCE
dc.identifier.isiut000310629700013
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.